Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Danaher Corporation before investing.

In this article, we go over a few key elements for understanding Danaher Corporation’s stock price such as:

• Danaher Corporation’s current stock price and volume
• Why Danaher Corporation’s stock price changed recently
• Upgrades and downgrades for DHR from analysts
• DHR’s stock price momentum as measured by its relative strength

About Danaher Corporation (DHR)

Before we jump into Danaher Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Want to learn more about Danaher Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Danaher Corporation.

Danaher Corporation’s Stock Price as of Market Close

As of July 31, 2026, 4:03 PM, CST, Danaher Corporation’s stock price was $194.980.

Danaher Corporation is down 0.61% from its previous closing price of $196.170.

During the last market session, Danaher Corporation’s stock traded between $192.620 and $198.570. Currently, there are approximately 705.30 million shares outstanding for Danaher Corporation.

Danaher Corporation’s price-earnings (P/E) ratio is currently at 34.9, which is low compared to the Life Sciences Tools & Services industry median of 43.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Danaher Corporation Stock Price History

Danaher Corporation’s (DHR) price is currently up 2.36% so far this month.

During the month of July, Danaher Corporation’s stock price has reached a high of $209.900 and a low of $165.750.

Over the last year, Danaher Corporation has hit prices as high as $242.800 and as low as $160.930. Year to date, Danaher Corporation’s stock is down 14.83%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Danaher Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded Danaher Corporation’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Danaher Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Danaher Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Danaher Corporation’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Danaher Corporation (DHR) by visiting AAII Stock Evaluator.

Relative Price Strength of Danaher Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Danaher Corporation has a weighted four-quarter relative price strength of -2.09%, which translates to a Momentum Score of 44 and is considered to be Average.

Want to learn more about how Danaher Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Danaher Corporation Stock Price: Bottom Line

As of July 31, 2026, Danaher Corporation’s stock price is $194.980, which is down 0.61% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Danaher Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.